FdaApplication
ANDA 202217
Identifiers
- fda_app_no: ANDA202217
Properties
| Property | Value |
|---|---|
| applicant_name | NOVEL LABORATORIES INC |
| application_type | ANDA |
| approval_date | 2014-08-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL | BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL |
1 product